Filing Details

Accession Number:
0001127602-24-022612
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-20 16:32:09
Reporting Period:
2024-08-16
Accepted Time:
2024-08-20 16:32:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1531048 Inari Medical Inc. NARI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1304099 William Hoffman C/O Inari Medical, Inc.
6001 Oak Canyon
Irvine CA 92618
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-08-16 24,553 $48.72 718,743 No 4 S Direct
Common Stock Disposition 2024-08-16 15,447 $49.17 703,296 No 4 S Direct
Common Stock Disposition 2024-08-19 20,000 $50.30 683,296 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2023.
  2. This transaction was executed in multiple trades at prices ranging from $48.05 to $49.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $49.05 to $49.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $50.00 to $50.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.